Abstract
We have synthesized multifunctional oxygen and paclitaxel loaded microbubbles (OPLMBs) for ultrasound mediated delivery of combination therapy in an ovarian cancer xenograft model. In comparison with other therapeutic options, intravenous injection of OPLMBs followed by ultrasound mediation yielded a superior therapeutic outcome. Immunohistochemical analyses of the dissected tumor tissue confirmed the increased tumor apoptosis and the reduced VEGF expression after treatment. Western Blot tests further confirmed the decreased expressions of HIF-1α and P-gp. Our experiment suggests that ultrasound mediation of OPLMBs may provide a promising drug delivery strategy for the combination treatment of ovarian cancer.
Keywords:
Drug delivery; Microbubbles; Ovarian cancer; Oxygen; Ultrasound.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Animals
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Apoptosis / drug effects
-
Apoptosis / radiation effects
-
Blotting, Western
-
Cell Proliferation / drug effects
-
Cell Proliferation / radiation effects
-
Combined Modality Therapy
-
Drug Delivery Systems*
-
Female
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
-
Lipids / chemistry*
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Microbubbles
-
Ovarian Neoplasms / metabolism
-
Ovarian Neoplasms / pathology*
-
Ovarian Neoplasms / therapy*
-
Oxygen / metabolism*
-
Paclitaxel / pharmacology*
-
Tumor Cells, Cultured
-
Ultrasonics*
-
Vascular Endothelial Growth Factor A / metabolism
-
Xenograft Model Antitumor Assays
Substances
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Antineoplastic Agents, Phytogenic
-
Hif1a protein, mouse
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
Lipids
-
Vascular Endothelial Growth Factor A
-
vascular endothelial growth factor A, mouse
-
Paclitaxel
-
Oxygen